14-day RSI
38.30
+1.11+2.98%
20 December 2024
Summary:
Adaptimmune Therapeutics stock 14-day relative strength index is 38.30, with the most recent change of +1.11 (+2.98%) on 20 December 2024. According to this value, ADAP stock is neither oversold nor overboughtADAP RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADAP RSI Performance
PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
---|---|---|---|---|
todaytoday | +3.0% | 0.0% | -0.7% | -0.6% |
1 m1 month | -0.7% | -8.5% | -15.5% | -7.3% |
3 m3 months | +3.9% | -39.2% | -37.7% | -5.5% |
6 m6 months | +20.9% | -32.0% | -33.4% | +10.6% |
ytdytd | -48.7% | -23.0% | +35.4% | +18.1% |
1 y1 year | +2.1% | +36.7% | +34.7% | +16.1% |
5 y5 years | -37.3% | -53.6% | -29.2% | -60.5% |
ADAP RSI High & Low
PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
---|---|---|---|---|---|
1 m | 1 month | 48.61 | -21.2% | 32.64 | +17.3% |
3 m | 3 months | 48.76 | -21.4% | 20.67 | +85.3% |
6 m | 6 months | 69.79 | -45.1% | 20.67 | +85.3% |
1 y | 1 year | 82.60 | -53.6% | 20.67 | +85.3% |
3 y | 3 years | 87.97 | -56.5% | 16.54 | +131.6% |
5 y | 5 years | 93.00 | -58.8% | 16.54 | +131.6% |
alltime | all time | 95.77 | -60.0% | 15.84 | +141.8% |
Adaptimmune Therapeutics Stock RSI History
Date | Value |
---|---|
2024 | 38.30(-48.7%) |
2023 | 74.60(+69.6%) |
2022 | 43.98(+1.6%) |
2021 | 43.29(-28.2%) |
2020 | 60.31(+21.3%) |
Date | Value |
---|---|
2019 | 49.73(-10.3%) |
2018 | 55.41(+80.1%) |
2017 | 30.76(-29.1%) |
2016 | 43.40(-35.0%) |
2015 | 66.78 |
FAQ
- What is Adaptimmune Therapeutics 14-day relative strength index?
- What is the all time high 14-day RSI for Adaptimmune Therapeutics?
What is Adaptimmune Therapeutics 14-day relative strength index?
The current 14-day RSI of ADAP is 38.30
What is the all time high 14-day RSI for Adaptimmune Therapeutics?
Adaptimmune Therapeutics all-time high 14-day relative strength index is 95.77